Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Plettenberg

Showing results (41-50 of 61) with videos related to

Pageof 7
Sort By:
Medizinische Klinik (Munich, Germany : 1983)|November 15, 1991
[Effect of alfa-2b interferon on prognostic parameters and clinical events in HIV positive patients in the LAS/ARC stage]A Plettenberg, M Nilsson, W Bahlmann, et al.
Der Ophthalmologe : Zeitschrift Der Deutschen Ophthalmologischen Gesellschaft|June 1, 1993
[Secondary prevention of cytomegalovirus retinitis with ganciclovir]J Garweg, W Olszowski, V Knospe, et al.
HIV Medicine|December 12, 2001
Intensification of stable background therapy with abacavir in antiretroviral therapy experienced patients: 48-week data from a randomized, double-blind trialC Katlama, B Clotet, A Plettenberg, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|February 15, 2007
Evolving characteristics of toxoplasmosis in patients infected with human immunodeficiency virus-1: clinical course and Toxoplasma gondii-specific immune responsesC Hoffmann, M Ernst, P Meyer, et al.
Dermatology (Basel, Switzerland)|January 9, 2001
Bacillary angiomatosis in HIV-infected patients--an epidemiological and clinical studyA Plettenberg, T Lorenzen, B T Burtsche, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|November 1, 1996
Vascular endothelial growth factor production in normal epidermis and in benign and malignant epithelial skin tumorsW Weninger, A Uthman, J Pammer, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 7, 2002
Remission of cutaneous Mycobacterium haemophilum infection as a result of antiretroviral therapy in a Human Immunodeficiency Virus--infected patientV Paech, T Lorenzen, A von Krosigk, et al.
AIDS (London, England)|June 6, 2000
The role of abacavir (ABC, 1592) in antiretroviral therapy-experienced patients: results from a randomized, double-blind, trial. CNA3002 European Study TeamC Katlama, B Clotet, A Plettenberg, et al.
European Journal of Medical Research|July 16, 2002
HHV-8 DNA in blood and the development of HIV-associated Kaposi's sarcoma in the era of HAART--a prospective evaluationT Lorenzen, D Albrecht, V Paech, et al.
Sexually Transmitted Infections|November 21, 2001
Resistance analyses in HIV infected patients with a history of multiple antiretroviral treatment regimensA Plettenberg, D Albrecht, T Lorenzen, et al.
Pageof 7

Showing results (41-50 of 61) with videos related to

Sort By:
Pageof 7
Medizinische Klinik (Munich, Germany : 1983)|November 15, 1991
[Effect of alfa-2b interferon on prognostic parameters and clinical events in HIV positive patients in the LAS/ARC stage]A Plettenberg, M Nilsson, W Bahlmann, et al.
Der Ophthalmologe : Zeitschrift Der Deutschen Ophthalmologischen Gesellschaft|June 1, 1993
[Secondary prevention of cytomegalovirus retinitis with ganciclovir]J Garweg, W Olszowski, V Knospe, et al.
HIV Medicine|December 12, 2001
Intensification of stable background therapy with abacavir in antiretroviral therapy experienced patients: 48-week data from a randomized, double-blind trialC Katlama, B Clotet, A Plettenberg, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|February 15, 2007
Evolving characteristics of toxoplasmosis in patients infected with human immunodeficiency virus-1: clinical course and Toxoplasma gondii-specific immune responsesC Hoffmann, M Ernst, P Meyer, et al.
Dermatology (Basel, Switzerland)|January 9, 2001
Bacillary angiomatosis in HIV-infected patients--an epidemiological and clinical studyA Plettenberg, T Lorenzen, B T Burtsche, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|November 1, 1996
Vascular endothelial growth factor production in normal epidermis and in benign and malignant epithelial skin tumorsW Weninger, A Uthman, J Pammer, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 7, 2002
Remission of cutaneous Mycobacterium haemophilum infection as a result of antiretroviral therapy in a Human Immunodeficiency Virus--infected patientV Paech, T Lorenzen, A von Krosigk, et al.
AIDS (London, England)|June 6, 2000
The role of abacavir (ABC, 1592) in antiretroviral therapy-experienced patients: results from a randomized, double-blind, trial. CNA3002 European Study TeamC Katlama, B Clotet, A Plettenberg, et al.
European Journal of Medical Research|July 16, 2002
HHV-8 DNA in blood and the development of HIV-associated Kaposi's sarcoma in the era of HAART--a prospective evaluationT Lorenzen, D Albrecht, V Paech, et al.
Sexually Transmitted Infections|November 21, 2001
Resistance analyses in HIV infected patients with a history of multiple antiretroviral treatment regimensA Plettenberg, D Albrecht, T Lorenzen, et al.
Pageof 7